Inituomab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Inituomab, covering 2022-07-06 to 2022-07-06. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Inituomab, Pyrrolidone and Nab-paclitaxel for HER2+Breast Cancer [Phase 2]